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Acquiring central venous pressure (CVP), an important clinical parameter, requires an inva-
sive procedure, which poses risk to patients. The aim of the study was to develop a non-
invasive methodology for determining mean-CVP from ultrasound assessment of the jugular
venous pulse.
Methods
In thirty-four adult patients (age = 60 ± 12 years; 10 males), CVP was measured using a cen-
tral venous catheter, with internal jugular vein (IJV) cross-sectional area (CSA) variation
along the cardiac beat acquired using ultrasound. The resultant CVP and IJV-CSA signals
were synchronized with electrocardiogram (ECG) signals acquired from the patients. Auto-
correlation signals were derived from the IJV-CSA signals using algorithms in R (open-
source statistical software). The correlation r-values for successive lag intervals were
extracted and used to build a linear regression model in which mean-CVP was the response
variable and the lagging autocorrelation r-values and mean IJV-CSA, were the predictor var-
iables. The optimum model was identified using the minimum AIC value and validated using
10-fold cross-validation.
Results
While the CVP and IJV-CSA signals were poorly correlated (mean r = -0.018, SD = 0.357)
due to the IJV-CSA signal lagging behind the CVP signal, their autocorrelation counterparts
were highly positively correlated (mean r = 0.725, SD = 0.215). Using the lagging autocorre-
lation r-values as predictors, mean-CVP was predicted with reasonable accuracy (r2 =
0.612), with a mean-absolute-error of 1.455 cmH2O, which rose to 2.436 cmH2O when
cross-validation was performed.
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Conclusions
Mean-CVP can be estimated non-invasively by using the lagged autocorrelation r-values of
the IJV-CSA signal. This new methodology may have considerable potential as a clinical
monitoring and diagnostic tool.
Introduction
The jugular venous pulse (JVP), a pivotal parameter of efficient cardiac function, reflects pres-
sure variation in the right atrium over the cardiac cycle [1]. It is represented by changes in the
cross-sectional area (CSA) of the internal jugular veins (IJVs) that can be easily monitored
using high resolution B-mode sonography [2, 3]. The IJVs readily respond to changes in trans-
mural pressure because they are thin-walled floppy vessels, with the result that the CSA of
these vessels fluctuates in a cyclical motion that is influenced by both the cardiac and respira-
tory cycles [2]. However, despite its importance, JVP evaluation is often neglected in clinical
practice [4], with central venous pressure (CVP) (i.e. the pressure in the right atrium and ven-
tricle at the end of diastole) being the parameter most commonly evaluated. CVP is a variable
indicative of cardiovascular function, having the dual role of distending the diastolic right ven-
tricle and opposing venous return [5]. As such, CVP is a useful guide for assessing cardiac pre-
load and vascular volume status, as well as being an indicator that can assist in better
understanding the reasons for changes in cardiac output, given the interaction that exists
between cardiac function and venous return [6]. Its measurement remains widely used in
intensive care units and emergency centers mainly for guiding fluid administration in patients
with haemodynamic instability [7]. CVP is invasively acquired, requiring the insertion of a
catheter via the IJV or subclavian veins. Furthermore, the procedure has inherent drawbacks
because it requires high levels of skill and carries a significant risk of complication [8]. Conse-
quently, there is a need to develop a non-invasive methodology for accurately assessing CVP.
Significant correlations have been reported between CVP and: (i) IJV-CSA [9, 10]; (ii) the
IJV/common carotid artery CSA ratio [9–11]; and (iii) the external jugular venous pulse [12].
This led us to hypothesize that it should be possible to predict CVP from the JVP [13]. Indeed,
several methods have been reported for monitoring CVP non-invasively [12, 14–18], although
none, with the exception of near-infrared spectroscopy (NIRS) [12], have demonstrated suffi-
cient accuracy and precision or ease of use. Recently an ultrasonographic (US) technique for
obtaining the JVP from a high-resolution B-mode sonogram sequences (US-JVP), recording
the changes in IJV-CSA over the cardiac cycle (CC), has been proposed [19], which appears to
have potential as an approach for estimating CVP. We therefore undertook the exploratory
study presented here with the aim of testing the efficacy (proof-of-concept) of a new method-
ology (also presented here) for estimating CVP purely from changes in IJV-CSA acquired
through US investigation. This methodology, which utilizes the autocorrelation signal of the
JVP (i.e. changes in IJV-CSA over the CC) and reflects the spectral characteristics of the CVP
pulse, is described in the Theory part of theMethods section below, which outlines the theory
underpinning the autocorrelation technique. Importantly, the methodology is generic and can
be applied to individual patients, without any prior knowledge of the CVP pulse or of the
patient’s anatomical features (e.g. length of neck, etc).
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Methods
The study was performed prospectively by a team composed of clinicians, technicians, physi-
cists and bio-engineers, and included a data collection phase, a post-processing phase and a
data analysis phase. The study was part of a project granted by the Italian Health Ministry
(Ricerca Finalizzata 2013, RF-2013-02358029) that was approved by the Ethics Committee of
Ferrara, Italy (reference No.160499). The study was carried out in accordance with the ethical
guidelines on good clinical practice as laid down in European Directive and the Declaration of
Helsinki. The trial was registered NCT03917368 (https://clinicaltrials.gov/ct2/show/
NCT03917368).
Data collection
The data collection phase, implemented at the University Hospital of Ferrara (Italy), included
the direct invasive measurement of the CVP and the US evaluation of the JVP. Both assess-
ments were performed at the same time.
Subjects
From September 2016 to July 2018, fifty-eight consecutive subjects (21 males and 37 females;
mean age 61 ± 3 years) were enrolled as the sample study group. Participants were selected
from hospitalised adult patients at University Hospital of Ferrara (Italy) requiring a scheduled
central venous catheterisation (CVC) and measurement of the CVP as part of their usual care.
Inclusion criteria were: age�18 years, spontaneous breathing and capacity to give informed
consent. Patients were excluded if they needed a cannulation via the internal jugular venous
access in order not to interfere with the ultrasound assessment, or if they were pregnant. In
addition, because high quality US images and JVP trace data were required in order to develop
the diagnostic model, any subjects who yielded corrupted or technically imperfect images or
signals were also excluded. All participants were approached before the CVC procedure and
signed a written informed consent form.
Direct invasive measurement of the CVP
In a surgery room, after moderate sedation (midazolam 4 mg intravenous) and subcutaneous
infiltration of local anaesthetics (mepivacaine 1% 20 ml), patients undertook a standardized
subclavian tunnelled catheterization by infraclavicular approach, under fluoroscopic control.
Following the catheterisation, patients were placed out of the surgery room lying completely
supine on a bed in order to measure the CVP according to the standard [20]. The central
venous catheter was connected to intravenous fluid within a pressure bag inflated up to 300
mmHg. The pressure measurement system was placed on the right or left arm at the level of
the fifth rib (phlebostatic axis) and the zero reference was checked and calibrated when neces-
sary. Three electrodes were placed on patients’ chests for the simultaneous assessment of the
electrocardiogram (ECG) signal. The pressure line and the ECG cables were connected to a
standard analogue monitor (Philips M3046A M4, Philips Medical System, Boeblingen, Ger-
many), which in turn was connected to a video grabber system, allowing the capture and stor-
age of the screen images on a computer, as they were not directly accessible in their digital
format. A single investigator performed all the central venous catheter measurements, which
served as the ‘gold standard’ measurement of CVP value and waveform.
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US assessment of the IJVs
Alongside the direct CVP measurement, the US assessment of the IJVs (both right and left)
was performed as previously described [3, 21]. A Vivid-q ultrasound system (GE Medical Sys-
tems, Horten, Norway) equipped with a linear array probe L12-RS (7.5–11 MHz) was used.
Patients were asked to maintain their neck in a fixed position on the longitudinal axis, avoiding
flexion, hyperextension and rotation, which might compress the veins and influence the mea-
surements. The probe, smeared with a copious amount of gel, was placed on the patients’ neck
in a transverse plane with respect to the length of the vessels, at the level of C5-C6, the so-called
J2 plane [22]. The IJV-CSA was insonated trying to avoid any pressure on the vessel and a B-
mode video-clip of 10–15 sec was recorded and stored. This was sufficient time to record sev-
eral cardiac cycles and two or three respiratory cycles. The ECG trace was automatically
recorded contextually with the IJV-CSA B-mode images. All the US evaluations were per-
formed by a single investigator.
Post-processing
The stored US IJV video clips and the CVP images were processed off-line to obtain a numeri-
cal dataset to enable the subsequent analyses and formulation of models. First of all, images
and video clips were elaborated with the software ImageJ [23] (e.g. Fig 1). The procedure to
obtain an IJV-CSA dataset of signals over time consisted of several passages both manual and
automatic. This procedure provided the IJV-CSA values in cm2 versus sonogram acquisition
time, the obtained result corresponded to the JVP trace (e.g. Fig 1) [3, 19, 21], whereas the
CVP time series signal dataset was produced by digitally identifying the position of each point
of the CVP trace represented on the acquired image. Subsequently the JVP and the CVP traces
were synchronised using the ECG signal recorded together with the measurements. Finally,
the obtained datasets were elaborated with Matlab (MathWorks, Inc.) and R software [24] to
remove the frequencies of non-cardiac origin, mainly CSA variations due to activation of the
thoracic pump [25]. This removed noise from the traces, therefore highlighting the contribu-
tion of the cardiac contraction to both traces [21, 26]. Finally, the post processing aimed to
conform the length of the traces making the comparison easier.
Theory
While the relationship between the IJV-CSA and CVP signals is difficult to interpret in the
time domain, it has been shown that in the frequency domain the two signals share similar
spectral characteristics [27]. Therefore, in theory it should be possible to determine a great
deal about the CVP signal purely through examination of the IJV pulse. However, factors such
as respiration influence the IJV pulse and there is a phase lag between the CVP pulse and the
IJV pulse, which makes it difficult to interpret the relationship between the two signals.
Autocorrelation, which assesses the degree of similarity between a given time series signal
and a lagged version of itself over successive time intervals, can be used to gain insights into
the spectral characteristics of signals. Through the Wiener–Khinchin theorem it can be shown
that the Fourier transform (used in Fourier analysis) is closely related to the autocorrelation
function of a signal [28]. As such, the autocorrelation signal can be used to assess the periodic-





Where: f is the frequency of the time series signal; D is the lag distance between successive
peaks in the autocorrelogram; and dt is the sampling interval.
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Fig 1. ImageJ custom plugin to detect area variations: The top figure shows an example of B-mode image with a rectangular Region of
Interest (ROI) and synchronized ECG trace, together with a list of ROIs and collected measurements. The bottom figure shows the indicative
JVP trace with a, c, v peaks and x, y troughs synchronized with the ECG trace. Systole and diastole phase as well as the corresponding opening and
closure of the tricuspid valve and various time intervals (Δt) are also shown.
https://doi.org/10.1371/journal.pone.0240057.g001
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Because the autocorrelation function reflects the spectral characteristics of signals, if two
time series signals such as the IJV and CVP pulses share similarities in the frequency domain,
then their respective autocorrelation signals will exhibit similarities and will tend to be aligned
irrespective of any lag between the two signals in the time domain. This suggests that the auto-
correlation signal might be a useful tool with which to predict the characteristics of the CVP
pulse using the IJV pulse.
For any given time series signal the corresponding autocorrelation signal is simply a plot of
the changes in the correlation r-value as a function of delay. The autocorrelation r-value for
any given lag in a time series can be computed using Eq 2.
rh ¼
P






Where: rh is the r-value for any given lag; yt is the time series signal at lag = 0; yt+h is the time
series signal at lag = h; and �y is the mean of the time series signal.
From this it can be seen that the autocorrelation signal is strongly influenced by the mean
of the measured signal in the time domain. Therefore, it can be hypothesized that it should be
possible to estimate the mean of the CVP pulse directly from the autocorrelation signal of the
IJV pulse, provided that the two share similar spectral characteristics.
Data analysis
Signal processing and statistical analysis were undertaken using in-house algorithms written
in R [24]. The relationship between the IJV-CSA and CVP time series signals for the respective
subjects was assessed using Pearson correlation analysis, with the time lag between the two sig-
nals computed using the ‘ccf’ cross-correlation function in R. For each patient, the autocorrela-
tion signals were derived from the IJV-CSA and CVP time series signals using the ‘acf’
function in R. From these, the correlation r-values for successive lags of 20 time intervals from
0 to 360 (i.e. 0, 20, 40, 60, . . . 360 intervals) were extracted and used to build the CVP predic-
tion model. Fourier analysis was also performed using the ‘fft’ function in R to produce period-
ograms for each patient. From these the five most dominant frequencies (with amplitudes)
were extracted for each patient. A linear regression model was then produced with mean CVP
as the response (dependent) variable and the extracted autocorrelation r-values for the succes-
sive lags, together with the mean IJV-CSA value, as the predictor (independent) variables. The
model was then refined using an in-house algorithm, which assessed all possible combinations
of the predictor variables to identify the model with the minimum Akaike information crite-
rion (AIC). The refined linear model was then used to predict the mean CVP for the respective
subjects. Finally, in order to assess the general applicability of the refined model and to test its
robustness as a predictor of mean CVP, 10-fold cross-validation was performed. This gave an
indication of how well the model might perform in ‘real life’ clinical situations. In addition, a
post-hoc statistical power calculation was performed using Cohen’s f2 with alpha = 0.05.
In order to test its clinical efficacy, the regression model was further evaluated by splitting
the outcomes into three categories: (i) CVP within the normal range, 2–8 mmHg (2.72–10.88
cmH2O) [29, 30]; (ii) CVP above the normal range; and (iii) CVP below the normal range. For
each class the sensitivity score was computed, together with overall accuracy achieved by the
model, which was also statistically evaluated using Cohen’s Kappa statistic for measuring
agreement.
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Results
The clinical US assessment of the IJVs and the invasive CVP measurement were completed in
all 58 enrolled patients. The post-processing phase revealed a number of technical imperfec-
tions and/or subject related abnormalities (ECG trace or CVP images not recorded, n = 6;
IJV-CSA edges not perfectly outlined, n = 4; CVP images not readable, n = 3; abnormal ECG,
n = 5; abnormal IJV-CSA size, n = 6), which potentially could compromise model develop-
ment. These traces were therefore deemed to be technically imperfect, and so the US video
clips and CVP images from the 24 affected subjects were excluded from the post-processing
phase in order to obtain a reliable dataset to analyse. In addition, in order to reduce the
amount of data, only the right IJV US video clips were considered for this study. The right IJV
was selected because this vessel is closer to the heart than the left IJV and thus is the dominant
side in 80% of individuals. The clinical characteristics of the remaining 34 subjects are summa-
rized in Table 1. Video clips and images from the remaining 34 subjects (age = 60 ± 12 years;
10 males/24 females) were finally processed and analysed (Fig 2). Sample results obtained dur-
ing the post-processing phase are shown in S1 Table.
The results of the autocorrelation analysis are presented in Table 2 and in Fig 3, while the
spectral analysis results are presented in S2 and S3 Tables. Collectively, these reveal that while
the CVP and IJV-CSA time series signals were poorly correlated (mean r = -0.018,
SD = 0.357), their autocorrelation counterparts were highly positively correlated (mean
r = 0.725, SD = 0.215) (Table 3). The poor correlation between the time series signals was in
part due to the fact that the IJV-CSA signal lagged behind the CVP signal by on average 0.241 s
(SD = 0.175 s) (Table 3), whereas in the autocorrelation signals were generally aligned because
both pulses exhibited similar spectral characteristics (S2 and S3 Tables). This is well illustrated
in Fig 4, which shows: (a) the normalized time series signals; (b) the autocorrelation signals;
and (c) the combined periodogram, relating to Subject 19. From the periodogram in Fig 4(c) it
can be seen that while both signals are dominated by a strong peak at 0.95 Hz, the CVP pulse
exhibits a strong second peak at about 1.90–2.14 Hz, which is much weaker in the IJV-CSA
Table 1. Clinical characteristics of subjects.
Age (ys) 60±11
Male/female ratio 10/24
Main diseases, n (%)
Neoplasia 34 (100%)
Coronary artery disease 3 (9%)












Values are given as means ± SD for continuous variables and numbers for categorical variables.
https://doi.org/10.1371/journal.pone.0240057.t001
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pulse. This difference is reflected in the respective autocorrelation signals in Fig 4(b), which
reveal that although both signals have the same general periodicity (indicating the dominance
of a single frequency in both signals), the CVP autocorrelation signal is more complex, indicat-
ing that it is affected to a greater extent by other additional frequencies.
The refined regression model results are presented in Table 4 and in Fig 5. This suggests
that the simple algorithm shown in Eq 3 can be used to predict mean CVP with reasonable
accuracy (r2 = 0.612) using just the mean IJV-CSA value and selected autocorrelation r-values
as predictors. Post-hoc analysis revealed Cohen’s f2 to be 1.577 with a statistical power of
0.993.
CVPpred ¼ ð2:836� CSAmeanÞ   ð32:469� lag40Þ   ð22:015� lag80Þ   ð7:590� lag100Þ 
ð18:417� lag120Þ   ð14:016� lag140Þ   ð23:054� lag180Þ   ð11:470� lag220Þ 
ð5:513� lag240Þ   ð8:478� lag280Þ   ð7:059� lag320Þ   10:014
ð3Þ
Where: CVPpred is the predicted CVP; CSAmean is the mean IJV-CSA; and lag 20–340 are the r-
values for the specified lags extracted from the autocorrelation signal. This linear model pre-
dicted the mean CVP for the respective subjects (Fig 4) with a mean-absolute-error (mae) of
1.455 cmH2O, which rose to 2.436 cmH2O when 10-fold cross-validation was performed.
Fig 2. Flow diagram showing subject enrolment and exclusion.
https://doi.org/10.1371/journal.pone.0240057.g002
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With regards to clinical classification, the model correctly identified 26 out of 27 subjects
(sensitivity = 96.3%) as having normal CVP; 0 out of 1 subject (sensitivity = 0.0%) as having a
high CVP; and 3 out of 6 subjects (sensitivity = 50.0%) as having a low CVP. The overall classi-
fication accuracy of the model was 85.3% (Kappa = 0.472).
Discussion
The jugular venous pulse is a physiological and pivotal parameter to describe cardio-circula-
tory function, as well as cardiac preload. In current clinical practice, it is a parameter that over
time has been abandoned due to difficulty in creating reliable measurements when physically
examining patients. The corresponding invasive ‘gold standard’, CVC, and the simultaneous
diffusion of echocardiography, have in fact greatly reduced its use in clinical practice. How-
ever, CVC, being an invasive technique, has the great disadvantage that it is associated with an
increased risk of clinical complications [8]. Therefore, the creation of a model that allows CVP
to be detected quickly, reliably and non-invasively represents an important development, one
that has relevance to several clinical applications, including the management of heart failure.
In particular, it may be useful when monitoring drug therapy over time, something that cannot
easily be done using echocardiography or an invasive manoeuvre. Therefore, having a rapid






















Mean (cmH2O & cm
2) 34 5.998 2.874 1.066 10.896 34 0.984 0.497 0.193 1.908
sd (cmH2O & cm
2) 34 1.21 0.462 0.554 2.173 34 0.05 0.03 0.008 0.114
Median (cmH2O & cm
2) 34 6.002 2.893 0.758 10.819 34 0.979 0.497 0.185 1.897
Min (cmH2O & cm
2) 34 3.422 3.355 -2.271 9.664 34 0.879 0.466 0.125 1.813
Max (cmH2O & cm
2) 34 8.667 2.660 3.34 12.739 34 1.090 0.525 0.287 2.040
lag0 (r-value) 34 1.000 0.000 1.000 1.000 34 1.000 0.000 1.000 1.000
lag20 (r-value) 34 0.127 0.339 -0.428 0.664 34 0.384 0.314 -0.429 0.841
lag40 (r-value) 34 -0.19 0.214 -0.549 0.264 34 -0.163 0.344 -0.830 0.542
lag60 (r-value) 34 -0.173 0.270 -0.636 0.587 34 -0.321 0.307 -0.784 0.602
lag80 (r-value) 34 -0.206 0.284 -0.64 0.731 34 -0.290 0.283 -0.656 0.642
lag100 (r-value) 34 -0.046 0.361 -0.572 0.727 34 -0.051 0.414 -0.643 0.682
lag120 (r-value) 34 0.046 0.354 -0.459 0.655 34 0.033 0.459 -0.723 0.767
lag140 (r-value) 34 0.061 0.263 -0.425 0.675 34 -0.039 0.397 -0.709 0.742
lag160 (r-value) 34 -0.036 0.304 -0.45 0.675 34 -0.097 0.332 -0.590 0.663
lag180 (r-value) 34 -0.085 0.250 -0.585 0.363 34 -0.114 0.314 -0.557 0.549
lag200 (r-value) 34 -0.012 0.265 -0.466 0.562 34 -0.034 0.316 -0.547 0.616
lag220 (r-value) 34 -0.041 0.254 -0.473 0.534 34 0.031 0.299 -0.583 0.632
lag240 (r-value) 34 0.054 0.250 -0.501 0.544 34 0.102 0.322 -0.459 0.674
lag260 (r-value) 34 0.078 0.279 -0.372 0.734 34 0.101 0.319 -0.370 0.835
lag280 (r-value) 34 -0.024 0.226 -0.349 0.552 34 0.050 0.287 -0.449 0.717
lag300 (r-value) 34 -0.018 0.197 -0.360 0.411 34 0.017 0.263 -0.425 0.574
lag320 (r-value) 34 0.027 0.237 -0.379 0.54 34 0.007 0.266 -0.420 0.566
lag340 (r-value) 34 0.044 0.193 -0.312 0.447 34 0.000 0.246 -0.387 0.597
lag360 (r-value) 34 -0.015 0.152 -0.429 0.304 34 -0.018 0.219 -0.494 0.483
CVP—central venous pressure; IJV-CSA—internal jugular vein cross-sectional area; n—number of observations; mean—mean value; sd—standard deviation; min—
minimum value; max—maximum value.
https://doi.org/10.1371/journal.pone.0240057.t002
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ultrasonographic test, which can also be performed by the general practitioner, could be deci-
sive in the global management of heart failure, a disease that is thought to affect approximately
1–2% in the western world, with an incidence rate approaching 5–10 per 1000 persons per
year [31], and which is more prevalent amongst the elderly and more common in women [32].
In addition, the non-invasive model could also be helpful in the evaluation of suspected hypo-
volemia, and cerebral venous return, or even in space medicine [21].
Fig 3. Mean ensemble autocorrelograms for the CVP and IJV CSA pulse signals (aggregated for all 34 subjects).
https://doi.org/10.1371/journal.pone.0240057.g003
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From the analysis presented above it can be seen that by utilizing the autocorrelation plot of
the IJV-CSA pulse it is possible to predict mean CVP with reasonable accuracy (r2 >0.6) using
a simple linear model. As such, we have been able to show that there is a clear relationship
between the mean of the CVP pulse and the autocorrelation signal of the IJV pulse, as sug-
gested by Eq 2. Having said this, we were somewhat surprised that the mean CVP could be
estimated with such accuracy using just a simple linear model, given that the autocorrelation


















1 0.877 0.992 -4.000 0.009 -0.035
4 -0.286 0.956 -37.000 0.007 -0.261
5 0.501 0.947 -12.000 0.008 -0.094
8 -0.004 0.561 -55.000 0.009 -0.478
10 0.205 0.659 -13.000 0.010 -0.130
15 -0.003 0.528 -88.000 0.009 -0.759
18 -0.204 0.680 -34.000 0.008 -0.262
19 -0.013 0.821 -29.000 0.006 -0.170
20 -0.239 0.550 -53.000 0.009 -0.491
23 -0.388 0.509 -31.000 0.007 -0.220
24 -0.284 0.229 -69.000 0.010 -0.690
25 -0.196 0.789 -17.000 0.010 -0.165
28 0.682 0.929 -1.000 0.008 -0.008
30 0.062 0.224 -35.000 0.004 -0.134
31 -0.052 0.679 -41.000 0.004 -0.161
34 0.096 0.771 -17.000 0.007 -0.120
38 -0.592 0.826 -30.000 0.009 -0.278
39 -0.366 0.787 -37.000 0.012 -0.430
40 -0.075 0.732 -28.000 0.008 -0.219
42 -0.150 0.927 -44.000 0.004 -0.173
44 -0.408 0.855 -40.000 0.006 -0.245
46 0.018 0.339 -22.000 0.008 -0.171
47 -0.686 0.930 -32.000 0.013 -0.400
48 -0.102 0.969 -17.000 0.016 -0.270
49 -0.149 0.729 -45.000 0.010 -0.455
50 -0.354 0.870 -34.000 0.008 -0.283
51 0.677 0.926 -17.000 0.005 -0.077
52 0.115 0.916 -51.000 0.004 -0.179
53 -0.112 0.584 -52.000 0.003 -0.156
54 0.481 0.957 -18.000 0.006 -0.112
55 0.342 0.726 -7.000 0.003 -0.024
56 0.219 0.803 -31.000 0.005 -0.150
57 -0.059 0.583 -42.000 0.003 -0.119
58 -0.175 0.373 -64.000 0.004 -0.262
mean -0.018 0.725 -33.735 0.007 -0.241
sd 0.357 0.215 19.181 0.003 0.175
mean—mean value; sd—standard deviation.
https://doi.org/10.1371/journal.pone.0240057.t003
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Fig 4. (a) Normalized time series signals; (b) autocorrelation signals; and (c) periodogram of the CVP and IJV
CSA pulses for Subject 19.
https://doi.org/10.1371/journal.pone.0240057.g004
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signal itself is non-linear. Indeed, it was only possible to use a linear model because the CSA
autocorrelation signals were dominated by a cardiac frequency of just under 1 Hz, which
meant that the CSA autocorrelation signals tended to exhibit a similar periodicity, as did many
of the CVP autocorrelation signals (as exemplified in Fig 4(b)). Consequently, there was a
broadly linear relationship between the extracted r-values for the respective lags and the CVP
mean values for the study cohort, which we were able to exploit.
While Fourier analysis is frequently used to establish the spectral characteristics of blood
vessels, in practice the frequency domain results produced can be difficult to interpret. By
comparison, we found the autocorrelation signals much easier to interpret because they cap-
tured the ‘combined effect’ of all the frequencies acting on the respective vessels. Thus, we
were able to quickly assess the similarities and dissimilarities between the respective signals
using just their autocorrelations, something, which would be more difficult to achieve using
either the time domain or frequency domain plots. For example, from Fig 4(b) it can be seen
that although the CVP autocorrelation signal for Subject 19 is influenced by a strong secondary
frequency of approximately 2 Hz (according to the periodogram in Fig 4(c)), this does not
affect the overall periodicity of the CVP autocorrelation signal, which is the same as that of the
CSA autocorrelation signal—something that is difficult to determine using either the respec-
tive time domain (Fig 4(a)) or frequency domain (Fig 4(c)) plots. As such, this suggests that
autocorrelation plots have considerable potential when comparing venous haemodynamic
signals.
Although in this initial proof-of-concept study we succeeded in producing an algorithm
that can approximately predict mean CVP from the IJV-CSA pulse, we are aware that despite
achieving an overall accuracy of 85%, the Kappa statistic was only 0.472, indicating just
Table 4. Refined multiple linear regression model with mean central venous pressure (CVP) as the response variable.
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moderately good performance when clinically classifying patients. However, this was achieved
using a simple linear model and a relatively small cohort, and it is anticipated that it should be
possible in future studies to improve the predictive accuracy of the model by utilising a sophis-
ticated machine learning strategy, such as a random forest [33]. Notwithstanding this, our
results are promising when compare with those achieved using existing methodologies. For
Fig 5. Regression scatter plot showing predicted and measured mean CVP values for the 34 subjects (units are in cmH2O).
https://doi.org/10.1371/journal.pone.0240057.g005
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example, CVP has traditionally been assessed through visual inspection of changes in volume
of the right IJV, when the upper body is inclined, using the sternal angle as the reference point.
However, the IJV is often obscured by the overlying neck tissues making clear visual identifica-
tion difficult, particularly for the less experienced examiner [34]. Consequently, the accuracy
of the visual inspection technique has been shown to be little better than about 50–60% [35,
36]. It should also be noted that substantial variations can occur in observed CVP due to errors
in transducer placement when taking invasive catheter measurements [37]. In the light of this,
the methodology presented here appears to have merit and potentially could be extremely
helpful particularly in emergency situations due to the speed with which vital information can
be obtained non-invasively using a simple ultrasound investigation that can be easily per-
formed at the patients’ bedside. Moreover, by utilising the model as a classification tool split
into three categories (normal, high and low CVP), it is possible to facilitate its applicability to
clinical practice.
One major limitation of out study is that the model was only tested on individuals with no
signs or symptoms of: chronic or acute heart failure; arrhythmias; or relevant stenosis/insuffi-
ciency of the cardiac valves. Thus, we recommend that in future studies the applicability of the
model to patients with concurrent heart diseases be studied as these might influence the behav-
iour of the algorithms used in the model. Also, because the model was produced using a rela-
tively small study cohort, we recommend that further studies be undertaken using a larger
cohort to confirm our findings and establish the sensitivity of the model. In addition, we are
conscious that in this study we only used data from the right IJV and it may be that utilising
both IJVs might produce superior results. However, none of our patients was affected by tri-
cuspid regurgitation or pulmonary hypertension. It is therefore recommended that future
work should explore both JVPs and their relationship with CVP in more challenging clinical
conditions. Finally, future studies should evaluate the US-JVP methodology against alternative
strategies such a NIRS.
In conclusion, we have been able to show that the autocorrelation signals of the respective
CVP and IJV-CSA pulses exhibit marked similarities, and that the lagging r-values of the auto-
correlation of the IJV-CSA pulse can be used to estimate mean CVP with reasonable accuracy.
This novel approach appears to have considerable clinical potential, because it allows CVP to
be measured non-invasively using ultrasonic assessment of the JVP. As such, the technique
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